Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,353 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
EFFICACY AND SAFETY OF BIOLOGICAL TREATMENT FOR INFLAMMATORY BOWEL DISEASE IN ELDERLY PATIENTS: RESULTS FROM A GETECCU COHORT.
Ferrer CS, Gismero FM, Caballol B, Ballester MP, Rey IB, García AC, Bautista JM, Chumillas RS, Benitez JM, Delgado LS, García AL, de Celix CR, Abreu IA, Melcarne L, Santos RP, Camí MM, Mateos AC, Díez CG, Calafat M, Galan HA, Vilaamil PV, Senosiain BC, Moya AG, Rodriguez Diaz CY, Spicakova K, Marcos NM, Molina G, Castro Parga L, Angulo AR, Del Campo LC, Rodriguez Grau MDC, Ramirez F, Pastrana BG, Partida IG, Mateu BB, Gonzalez EP, Iyo E, Gonzalez AE, Arnau ES, Villalba LH, Galindo PP, Medina LT, Alonso SM, Olmos Perez JA, Sadornil CD, Ramirez LG, Martín-Arranz MD, Sanroman AL, Fernández A, Murgui VM, Suárez CC, Florez P, Lobato Matilla ME, Sicilia B, Escribano PS, Martin CM, Mañosa M, De Acosta MB; On belhaf of Young group of GETECCU. Ferrer CS, et al. Among authors: suarez cc. Gastroenterol Hepatol. 2024 May 4:502197. doi: 10.1016/j.gastrohep.2024.502197. Online ahead of print. Gastroenterol Hepatol. 2024. PMID: 38710465 English, Spanish.
Nivolumab plus cabozantinib versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended follow-up from the phase III randomised CheckMate 9ER trial.
Powles T, Burotto M, Escudier B, Apolo AB, Bourlon MT, Shah AY, Suárez C, Porta C, Barrios CH, Richardet M, Gurney H, Kessler ER, Tomita Y, Bedke J, George S, Scheffold C, Wang P, Fedorov V, Motzer RJ, Choueiri TK. Powles T, et al. Among authors: suarez c. ESMO Open. 2024 Apr 19;9(5):102994. doi: 10.1016/j.esmoop.2024.102994. Online ahead of print. ESMO Open. 2024. PMID: 38642472 Free PMC article.
Identifying major histocompatibility complex class II-DR molecules in bovine and swine peripheral blood monocyte-derived macrophages using mAb-L243.
Celis-Giraldo C, Ordoñez D, Díaz-Arévalo D, Bohórquez MD, Ibarrola N, Suárez CF, Rodríguez K, Yepes Y, Rodríguez A, Avendaño C, López-Abán J, Manzano-Román R, Patarroyo MA. Celis-Giraldo C, et al. Among authors: suarez cf. Vaccine. 2024 Apr 16:S0264-410X(24)00467-5. doi: 10.1016/j.vaccine.2024.04.042. Online ahead of print. Vaccine. 2024. PMID: 38631956
Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.
Lü Y, Cho T, Mukherjee S, Suarez CF, Gonzalez-Foutel NS, Malik A, Martinez S, Dervovic D, Oh RH, Langille E, Al-Zahrani KN, Hoeg L, Lin ZY, Tsai R, Mbamalu G, Rotter V, Ashton-Prolla P, Moffat J, Chemes LB, Gingras AC, Oren M, Durocher D, Schramek D. Lü Y, et al. Among authors: suarez cf. Mol Syst Biol. 2024 Apr 5. doi: 10.1038/s44320-024-00032-x. Online ahead of print. Mol Syst Biol. 2024. PMID: 38580884 Free article.
1,353 results